Jagsonpal Pharmaceuticals informs about revised investor presentation

24 Oct 2024 Evaluate
In continuation to its earlier intimation dated October 23, 2024, Jagsonpal Pharmaceuticals has informed that it enclosed a copy of revised Investor Presentation for the Unaudited Financial results for the quarter and half year ended September 30, 2024, due to an inadvertent error in slide 20 which has been rectified.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

227.90 10.70 (4.93%)
02-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.25
Dr. Reddys Lab 1149.75
Cipla 1452.70
Lupin 2009.40
Zydus Lifesciences 891.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...